2C-B-AMINOREX

Details

Stereochemistry	RACEMIC
Molecular Formula	C11H13BrN2O3
Molecular Weight	301.137
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

COC1=CC(Br)=C(OC)C=C1C2CN=C(N)O2

InChI

InChIKey=XUTCHZHTIDHQOP-UHFFFAOYSA-N

InChI=1S/C11H13BrN2O3/c1-15-8-4-7(12)9(16-2)3-6(8)10-5-14-11(13)17-10/h3-4,10H,5H2,1-2H3,(H2,13,14)

HIDE SMILES / InChI

Molecular Formula	C11H13BrN2O3
Molecular Weight	301.137
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical
Record UNII	HBY9BQ3YJK
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

2C-B-AMINOREX

Common Name

English

5-(2,5-DIMETHOXY-4-BROMOPHENYL)-4,5-DIHYDRO-1,3-OXAZOL-2-AMINE

Systematic Name

English

2C-B AMINOREX

Common Name

English

Code System

Code

Type

Description

FDA UNII

HBY9BQ3YJK

PRIMARY

PUBCHEM

165360199

PRIMARY

Related Record Type Details


					CJZ26L1EGI

SODIUM-DEPENDENT SEROTONIN TRANSPORTER

TRANSPORTER -> SUBSTRATE

Comments:

Our data show that drugs known or suspected to increase the risk of PPH (eg, aminorex, fenfluramine, and chlorphentermine) are 5-HT transporter substrates, whereas drugs that have not been shown to increase the risk of PPH are less potent in this regard.

Amount: